LENZ Therapeutics Reports Q2 2026 Financial Results

What Happened
LENZ Therapeutics, Inc. announced its financial results for the quarter ended June 30, 2026 via a press release issued and filed on August 11, 2026. The company furnished this information on Form 8-K under Item 2.02 (Results of Operations and Financial Condition); the press release is attached as Exhibit 99.1 and incorporated by reference.

Key Details

• Filing date: August 11, 2026 (Form 8-K, Item 2.02).
• Reporting period: Quarter ended June 30, 2026 (quarterly results / earnings announcement).
• Exhibit 99.1: Press Release dated August 11, 2026; Exhibit 104: Cover Page Inline XBRL tags.
• Form 8-K signed by Daniel Chevallard, Chief Financial Officer, on August 11, 2026.

Why It Matters
This 8-K provides immediate access to LENZ’s latest quarterly results—information investors use to assess recent revenue, net income or loss, cash position, and operating trends. While the press release gives headline quarterly results, investors should review the attached release for specific figures and await the company’s upcoming 10-Q (or other filings) for full financial statements and management discussion. Tracking these results helps investors evaluate near-term performance and liquidity for LENZ Therapeutics.